In this episode, Fred Turner, CEO of Curative, shares the journey of scaling the company from a COVID-19 testing powerhouse to a disruptive force in the commercial health plan space. He discusses Curative’s unique no-deductible model, the importance of early patient engagement, and the challenges of entering a highly regulated industry dominated by a few major players.
Fred Turner, CEO of Curative
Next Up in Becker’s Payer Issues Podcast
-
In this episode, Alan Condon, Editor-in-Chief at Becker’s Healthcare, discusses the surge in health system M&A, including the proposed Intermountain…
-
In this episode, Eddie Wilson, Managing Director at Deloitte, and Yuchen Chen, Associate Vice President at Deloitte, discuss how healthcare…
-
In this episode, Nishith Khandwala, CEO and Co-founder at Bunkerhill Health, Sam Schwager, CEO & Co-Founder of SuperDial, Steve Liou,…
Comments are closed.